New diabetes clinical trial: SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes

Published on: June 11, 2019 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Drug: Metformin;   Drug: Dapagliflozin 10 MG
Sponsors:   Uppsala University;   Uppsala University Hospital;   Swedish Healthcare Regions;   Swedish National Board of Health and Welfare;   The Swedish National Diabetes Register
Recruiting